(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ICOSLG mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ICOSLG mRNA CTD PMID:22079256 1,2-dichloroethane affects expression ISO Icosl (Mus musculus) 6480464 ethylene dichloride affects the expression of ICOSL mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Icosl (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ICOSL mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Icosl (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ICOSL mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Icosl (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ICOSL mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Icosl (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of ICOSL mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ICOSLG mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO ICOSLG (Homo sapiens) 6480464 Estradiol results in increased expression of ICOSLG mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Icosl (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ICOSL mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ICOSL promoter] CTD PMID:17942748 and PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ICOSLG (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ICOSLG mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Icosl (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ICOSL mRNA CTD PMID:19933214 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ICOSLG mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Icosl (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ICOSL mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of ICOSLG mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases expression ISO Icosl (Mus musculus) 6480464 bisphenol S results in decreased expression of ICOSL mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO Icosl (Mus musculus) 6480464 Fenretinide results in increased expression of ICOSLG mRNA CTD PMID:28973697 aflatoxin B1 increases expression ISO ICOSLG (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ICOSLG mRNA CTD PMID:21641981 all-trans-retinoic acid decreases expression ISO ICOSLG (Homo sapiens) 6480464 Tretinoin results in decreased expression of ICOSLG mRNA CTD PMID:33167477 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ICOSLG mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO ICOSLG (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ICOSLG mRNA CTD PMID:24449571 aripiprazole multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of ICOSLG mRNA CTD PMID:31476115 aristolochic acid A increases expression ISO ICOSLG (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ICOSLG mRNA CTD PMID:33212167 arsenous acid decreases expression ISO ICOSLG (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ICOSLG mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO ICOSLG (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ICOSLG mRNA CTD PMID:22316170 and PMID:32234424 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ICOSLG mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ICOSLG mRNA CTD PMID:32145629 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ICOSLG mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ICOSLG mRNA CTD PMID:28628672 Bisphenol B increases expression ISO ICOSLG (Homo sapiens) 6480464 bisphenol B results in increased expression of ICOSLG mRNA CTD PMID:32387340 carbon nanotube decreases expression ISO Icosl (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of ICOSL mRNA CTD PMID:25554681 choline multiple interactions ISO Icosl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ICOSL mRNA CTD PMID:20938992 chromium(6+) affects expression ISO ICOSLG (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of ICOSLG mRNA CTD PMID:30690063 chrysene increases expression ISO Icosl (Mus musculus) 6480464 chrysene results in increased expression of ICOSL mRNA CTD PMID:26377693 cisplatin decreases expression ISO ICOSLG (Homo sapiens) 6480464 Cisplatin results in decreased expression of ICOSLG mRNA CTD PMID:27594783 cisplatin multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ICOSLG mRNA CTD PMID:27392435 cisplatin increases expression ISO ICOSLG (Homo sapiens) 6480464 Cisplatin results in increased expression of ICOSLG mRNA CTD PMID:27392435 cyclosporin A increases expression ISO ICOSLG (Homo sapiens) 6480464 Cyclosporine results in increased expression of ICOSLG mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ICOSLG mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO Icosl (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ICOSL mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO ICOSLG (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ICOSLG mRNA CTD PMID:22521957 dimethylselenide multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA and [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA CTD PMID:33656867 dioxygen increases expression ISO ICOSLG (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of ICOSLG mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ICOSLG mRNA CTD PMID:27188386 ethyl methanesulfonate increases expression ISO ICOSLG (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of ICOSLG mRNA CTD PMID:23649840 folic acid multiple interactions ISO Icosl (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 formaldehyde increases expression ISO ICOSLG (Homo sapiens) 6480464 Formaldehyde results in increased expression of ICOSLG mRNA CTD PMID:23649840 gallic acid increases expression ISO ICOSLG (Homo sapiens) 6480464 Gallic Acid results in increased expression of ICOSLG mRNA CTD PMID:34408198 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ICOSLG mRNA CTD PMID:33387578 hydroxyl multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA CTD PMID:33656867 indometacin multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ICOSLG mRNA CTD PMID:28628672 L-methionine multiple interactions ISO Icosl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ICOSL mRNA CTD PMID:20938992 lead(0) affects expression ISO ICOSLG (Homo sapiens) 6480464 Lead affects the expression of ICOSLG mRNA CTD PMID:28903495 leflunomide increases expression ISO ICOSLG (Homo sapiens) 6480464 leflunomide results in increased expression of ICOSLG mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO Icosl (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of ICOSL mRNA CTD PMID:25890327 menadione decreases expression ISO Icosl (Mus musculus) 6480464 Vitamin K 3 results in decreased expression of ICOSL mRNA CTD PMID:25270620 methotrexate decreases expression ISO ICOSLG (Homo sapiens) 6480464 Methotrexate results in decreased expression of ICOSLG mRNA CTD PMID:17400583 N-Nitrosopyrrolidine increases expression ISO ICOSLG (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of ICOSLG mRNA CTD PMID:32234424 ozone multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA and [Aripiprazole co-treated with Ozone] results in increased expression of ICOSLG mRNA CTD PMID:31476115 and PMID:33656867 ozone increases expression ISO ICOSLG (Homo sapiens) 6480464 Ozone results in increased expression of ICOSLG mRNA CTD PMID:31476115 p-chloromercuribenzoic acid increases expression ISO ICOSLG (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of ICOSLG mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ICOSLG mRNA CTD PMID:27188386 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of ICOSLG mRNA CTD PMID:27638505 paracetamol increases expression ISO ICOSLG (Homo sapiens) 6480464 Acetaminophen results in increased expression of ICOSLG mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ICOSLG mRNA CTD PMID:33387578 phenylmercury acetate increases expression ISO ICOSLG (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of ICOSLG mRNA CTD PMID:26272509 pirinixic acid increases expression ISO Icosl (Mus musculus) 6480464 pirinixic acid results in increased expression of ICOSL mRNA CTD PMID:20813756 potassium chromate decreases expression ISO ICOSLG (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ICOSLG mRNA CTD PMID:22079256 potassium chromate increases expression ISO ICOSLG (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of ICOSLG mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ICOSLG mRNA CTD PMID:22079256 potassium dichromate increases expression ISO Icosl (Mus musculus) 6480464 Potassium Dichromate results in increased expression of ICOSL mRNA CTD PMID:23608068 SB 431542 multiple interactions ISO ICOSLG (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ICOSLG mRNA CTD PMID:27188386 sunitinib increases expression ISO ICOSLG (Homo sapiens) 6480464 Sunitinib results in increased expression of ICOSLG mRNA CTD PMID:31533062 tamoxifen increases expression ISO Icosl (Mus musculus) 6480464 Tamoxifen results in increased expression of ICOSL mRNA CTD PMID:25123088 tamoxifen affects expression ISO Icosl (Mus musculus) 6480464 Tamoxifen affects the expression of ICOSL mRNA CTD PMID:17555576 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ICOSLG mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ICOSLG mRNA CTD PMID:31150632 tetraphene increases expression ISO Icosl (Mus musculus) 6480464 benz(a)anthracene results in increased expression of ICOSL mRNA CTD PMID:26377693 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ICOSLG mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide increases expression ISO Icosl (Mus musculus) 6480464 titanium dioxide results in increased expression of ICOSL mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO Icosl (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ICOSL mRNA CTD PMID:29950665 triclosan increases expression ISO ICOSLG (Homo sapiens) 6480464 Triclosan results in increased expression of ICOSLG mRNA CTD PMID:30510588 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ICOSLG mRNA CTD PMID:30589522 urethane decreases expression ISO ICOSLG (Homo sapiens) 6480464 Urethane results in decreased expression of ICOSLG mRNA CTD PMID:28818685 valproic acid increases methylation ISO ICOSLG (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ICOSLG gene CTD PMID:29154799 zoledronic acid increases expression ISO ICOSLG (Homo sapiens) 6480464 zoledronic acid results in increased expression of ICOSLG mRNA CTD PMID:24714768